Pediatric cerebral cavernous malformations and stereotactic radiosurgery: an analysis of 50 cases from a multicentric study.

Journal of neurosurgery. Pediatrics 2024 Vol.33(4) p. 315-322

Mantziaris G, Dumot C, Pikis S, Peker S, Samanci Y, Ardor GD, Nabeel AM, Reda WA, Tawadros SR, Abdel Karim K, El-Shehaby AMN, Emad Eldin RM, Elazzazi AH, Sheehan D, Sheehan K, Martínez Moreno N, Martínez Álvarez R, Liscak R, May J, Tripathi M, Rajput A, Kumar N, Kaur R, Alzate JD, Kondziolka D, Dayawansa S, Sheehan JP

관련 도메인

Abstract

[OBJECTIVE] Cerebral cavernous malformations (CCMs) are the second most common vascular anomaly affecting the CNS in children. Although stereotactic radiosurgery (SRS) has been proposed as an alternative to microsurgery in the management of selected cases in adults, there is a paucity of studies focusing on pediatric patients. The aim of this study was to present the outcomes and associated risks of SRS in this subgroup of patients.

[METHODS] This retrospective multicenter study included pediatric patients treated with single-session SRS for CCMs. The annual hemorrhage rate (AHR) was calculated before and after SRS in hemorrhagic lesions. The Engel classification was used to describe post-SRS epileptic control. Adverse radiation effects (AREs) and the occurrence of new neurological deficits were recorded.

[RESULTS] The study included 50 patients (median age 15.1 [IQR 5.6] years) harboring 62 CCMs. Forty-two (84%) and 22 (44%) patients had a history of hemorrhage or epilepsy prior to SRS, respectively. The AHR from diagnosis to SRS excluding the first hemorrhage was 7.19 per 100 CCM-years, dropping to 3.15 per 100 CCM-years after treatment. The cumulative risk of first hemorrhage after SRS was 7.4% (95% CI 0%-14.3%) at 5 years and 23.6% (95% CI 0%-42.2%) at 10 years. Eight hemorrhagic events involving 6 CCMs in 6 patients were recorded in the post-SRS follow-up period; 4 patients presented with transient symptoms and 4 with permanent symptoms. Of the 22 patients with pre-SRS seizures, 11 were seizure free at the last follow-up (Engel class I), 6 experienced improvement (Engel class II or III), 5 had no improvement (Engel class IVA or IVB), and 1 experienced worsening (Engel class IVC). Radiographic AREs were documented in 14.5% (9/62) of CCMs, with 4 being symptomatic.

[CONCLUSIONS] Single-session SRS reduces the CCM hemorrhage rate in the pediatric population and provides adequate seizure control.

추출된 의학 개체 (NER)

유형영어 표현한국어 / 풀이UMLS CUI출처등장
시술 microsurgery 미세수술 dict 1
해부 CNS scispacy 1
합병증 cerebral cavernous malformations scispacy 1
합병증 CCMs → Cerebral cavernous malformations scispacy 1
합병증 lesions scispacy 1
합병증 CCM scispacy 1
약물 IVA C0268575
Isovaleryl-CoA dehydrogenase deficiency
scispacy 1
약물 [OBJECTIVE] Cerebral cavernous malformations ( scispacy 1
약물 [CONCLUSIONS] scispacy 1
질환 cerebral cavernous malformations C2919945
Cavernous Hemangioma of Brain
scispacy 1
질환 CCMs → Cerebral cavernous malformations C2919945
Cavernous Hemangioma of Brain
scispacy 1
질환 vascular anomaly C0158570
Vascular anomaly
scispacy 1
질환 SRS → stereotactic radiosurgery C3846112
Radiosurgery, Stereotactic
scispacy 1
질환 hemorrhage C0019080
Hemorrhage
scispacy 1
질환 hemorrhagic lesions scispacy 1
질환 post-SRS epileptic scispacy 1
질환 neurological deficits C0521654
Neurologic Deficits
scispacy 1
질환 epilepsy C0014544
Epilepsy
scispacy 1
질환 hemorrhagic C0333275
Hemorrhagic
scispacy 1
질환 post-SRS scispacy 1
질환 seizures C0036572
Seizures
scispacy 1
질환 seizure C0036572
Seizures
scispacy 1
질환 CCM hemorrhage C0019080
Hemorrhage
scispacy 1
질환 AREs → Adverse radiation effects scispacy 1
기타 vascular scispacy 1
기타 children scispacy 1
기타 patients scispacy 1
기타 AHR → annual hemorrhage rate scispacy 1
기타 class II scispacy 1

MeSH Terms

Adult; Child; Humans; Adolescent; Treatment Outcome; Radiosurgery; Hemangioma, Cavernous, Central Nervous System; Seizures; Epilepsy; Cerebral Hemorrhage; Retrospective Studies; Intracranial Arteriovenous Malformations; Follow-Up Studies

🔗 함께 등장하는 도메인

이 논문이 속한 카테고리와 같은 논문에서 자주 함께 다뤄지는 카테고리들

관련 논문